Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Polycystic ovary syndrome and autism: A test of the prenatal sex steroid theory.

Cherskov A, Pohl A, Allison C, Zhang H, Payne RA, Baron-Cohen S.

Transl Psychiatry. 2018 Aug 1;8(1):136. doi: 10.1038/s41398-018-0186-7.

2.

Maternal Polycystic Ovary Syndrome and Risk for Attention-Deficit/Hyperactivity Disorder in the Offspring.

Kosidou K, Dalman C, Widman L, Arver S, Lee BK, Magnusson C, Gardner RM.

Biol Psychiatry. 2017 Nov 1;82(9):651-659. doi: 10.1016/j.biopsych.2016.09.022. Epub 2016 Oct 6.

3.

Maternal polycystic ovary syndrome and the risk of autism spectrum disorders in the offspring: a population-based nationwide study in Sweden.

Kosidou K, Dalman C, Widman L, Arver S, Lee BK, Magnusson C, Gardner RM.

Mol Psychiatry. 2016 Oct;21(10):1441-8. doi: 10.1038/mp.2015.183. Epub 2015 Dec 8.

4.

Pervasive developmental disorders in children of hyperandrogenic women with polycystic ovary syndrome: a longitudinal case-control study.

Palomba S, Marotta R, Di Cello A, Russo T, Falbo A, Orio F, Tolino A, Zullo F, Esposito R, La Sala GB.

Clin Endocrinol (Oxf). 2012 Dec;77(6):898-904. doi: 10.1111/j.1365-2265.2012.04443.x.

PMID:
22612600
5.

Maternal hirsutism and autism spectrum disorders in offspring.

Lee BK, Arver S, Widman L, Gardner RM, Magnusson C, Dalman C, Kosidou K.

Autism Res. 2017 Sep;10(9):1544-1546. doi: 10.1002/aur.1797. Epub 2017 Apr 6.

PMID:
28383189
6.

Testosterone Levels in Third Trimester in Polycystic Ovary Syndrome: Odense Child Cohort.

Glintborg D, Jensen RC, Bentsen K, Schmedes AV, Brandslund I, Kyhl HB, Bilenberg N, Andersen MS.

J Clin Endocrinol Metab. 2018 Oct 1;103(10):3819-3827. doi: 10.1210/jc.2018-00889.

PMID:
30060213
7.

Endocrine and cardiometabolic cord blood characteristics of offspring born to mothers with and without polycystic ovary syndrome.

Daan NM, Koster MP, Steegers-Theunissen RP, Eijkemans MJ, Fauser BC.

Fertil Steril. 2017 Jan;107(1):261-268.e3. doi: 10.1016/j.fertnstert.2016.09.042. Epub 2016 Oct 27.

PMID:
28228318
9.

The role of serum testosterone in early pregnancy outcome: a comparison in women with and without polycystic ovary syndrome.

Lathi RB, Dahan MH, Reynolds-May MF, Milki AA, Behr B, Westphal LM.

J Obstet Gynaecol Can. 2014 Sep;36(9):811-816. doi: 10.1016/S1701-2163(15)30483-7.

PMID:
25222360
10.

Fetal-maternal outcomes and complications in pregnant women with polycystic ovary syndrome.

Klevedal C, Turkmen S.

Minerva Ginecol. 2017 Apr;69(2):141-149. doi: 10.23736/S0026-4784.16.03946-0. Epub 2016 Jun 16.

PMID:
27310674
11.

Opposing effects of dehydroepiandrosterone sulfate and free testosterone on metabolic phenotype in women with polycystic ovary syndrome.

Lerchbaum E, Schwetz V, Giuliani A, Pieber TR, Obermayer-Pietsch B.

Fertil Steril. 2012 Nov;98(5):1318-25.e1. doi: 10.1016/j.fertnstert.2012.07.1057. Epub 2012 Jul 24.

PMID:
22835450
12.

Umbilical vein testosterone in female infants born to mothers with polycystic ovary syndrome is elevated to male levels.

Barry JA, Kay AR, Navaratnarajah R, Iqbal S, Bamfo JE, David AL, Hines M, Hardiman PJ.

J Obstet Gynaecol. 2010;30(5):444-6. doi: 10.3109/01443615.2010.485254.

PMID:
20604643
13.

Elevated circulating levels of betatrophin are associated with polycystic ovary syndrome.

Calan M, Yilmaz O, Kume T, Unal Kocabas G, Yesil Senses P, Senses YM, Temur M, Gursoy Calan O.

Endocrine. 2016 Jul;53(1):271-9. doi: 10.1007/s12020-016-0875-z. Epub 2016 Feb 1.

PMID:
26832343
14.

Polycystic ovary syndrome and psychiatric disorders: Co-morbidity and heritability in a nationwide Swedish cohort.

Cesta CE, Månsson M, Palm C, Lichtenstein P, Iliadou AN, Landén M.

Psychoneuroendocrinology. 2016 Nov;73:196-203. doi: 10.1016/j.psyneuen.2016.08.005. Epub 2016 Aug 3.

PMID:
27513883
15.

Effect of exposure to second-hand smoke from husbands on biochemical hyperandrogenism, metabolic syndrome and conception rates in women with polycystic ovary syndrome undergoing ovulation induction.

Li J, Wu Q, Wu XK, Zhou ZM, Fu P, Chen XH, Yan Y, Wang X, Yang ZW, Li WL, Stener-Victorin E, Legro RS, Ng EH, Zhang H, Mol BWJ, Wang CC; for PCOSAct Study Group.

Hum Reprod. 2018 Apr 1;33(4):617-625. doi: 10.1093/humrep/dey027.

PMID:
29471520
16.

Polycystic Ovary Syndrome Is Associated With Adverse Mental Health and Neurodevelopmental Outcomes.

Berni TR, Morgan CL, Berni ER, Rees DA.

J Clin Endocrinol Metab. 2018 Jun 1;103(6):2116-2125. doi: 10.1210/jc.2017-02667.

PMID:
29648599
17.

Antimüllerian hormone levels and cardiometabolic risk in young women with polycystic ovary syndrome.

Feldman RA, O'Neill K, Butts SF, Dokras A.

Fertil Steril. 2017 Jan;107(1):276-281. doi: 10.1016/j.fertnstert.2016.10.009. Epub 2016 Nov 11.

PMID:
27842995
18.

Implications of polycystic ovary syndrome for pregnancy and for the health of offspring.

Doherty DA, Newnham JP, Bower C, Hart R.

Obstet Gynecol. 2015 Jun;125(6):1397-406. doi: 10.1097/AOG.0000000000000852.

PMID:
26000511
19.

Irregular menstruation and hyperandrogenaemia in adolescence are associated with polycystic ovary syndrome and infertility in later life: Northern Finland Birth Cohort 1986 study.

West S, Lashen H, Bloigu A, Franks S, Puukka K, Ruokonen A, Järvelin MR, Tapanainen JS, Morin-Papunen L.

Hum Reprod. 2014 Oct 10;29(10):2339-51. doi: 10.1093/humrep/deu200. Epub 2014 Aug 1.

20.

Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database.

Kumarendran B, O'Reilly MW, Manolopoulos KN, Toulis KA, Gokhale KM, Sitch AJ, Wijeyaratne CN, Coomarasamy A, Arlt W, Nirantharakumar K.

PLoS Med. 2018 Mar 28;15(3):e1002542. doi: 10.1371/journal.pmed.1002542. eCollection 2018 Mar.

Supplemental Content

Support Center